GlaxoSmithKline agreed to pay $750 million

WSJ Law Blog: “The big law-and-biz headline from Wednesday involved drug maker GlaxoSmithKline, which agreed to pay $750 million and enter a guilty plea to settle charges that it put bad drugs into the stream of commerce.”

Receive our latest news updates on Twitter, Facebook and your inbox.